LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 146 filers reported holding LOXO ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $870,000 | -18.0% | 6,210 | 0.0% | 1.92% | -24.4% |
| Q3 2018 | $1,061,000 | -11.4% | 6,210 | -10.0% | 2.53% | -2.4% |
| Q2 2018 | $1,197,000 | +50.4% | 6,900 | 0.0% | 2.60% | +66.3% |
| Q1 2018 | $796,000 | -31.5% | 6,900 | -50.0% | 1.56% | +55.3% |
| Q4 2017 | $1,162,000 | -8.6% | 13,800 | 0.0% | 1.00% | -11.8% |
| Q3 2017 | $1,271,000 | +14.8% | 13,800 | 0.0% | 1.14% | +12.4% |
| Q2 2017 | $1,107,000 | +12.5% | 13,800 | -61.7% | 1.01% | +33.2% |
| Q1 2016 | $984,000 | -42.4% | 36,000 | -40.0% | 0.76% | -32.5% |
| Q4 2015 | $1,707,000 | – | 60,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |